Stay updated on BBP-398 + Osimertinib in EGFR+ NSCLC: Clinical Trial

Sign up to get notified when there's something new on the BBP-398 + Osimertinib in EGFR+ NSCLC: Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the BBP-398 + Osimertinib in EGFR+ NSCLC: Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    The study record now shows recruitment has ended, indicating the trial is not enrolling any more participants. Added navigation/help items (How to Read a Study Record, Common Questions, How to Join a Study) and a site revision label (Revision: v3.6.0); the header formatting around Intervention/Treatment was updated.
    Difference
    0.6%
    Check dated 2026-06-15T19:00:44.000Z thumbnail image
  2. Check
    13 days ago
    Change Detected
    Summary
    The page revision was updated from v3.5.4 to v3.5.5. This indicates a behind-the-scenes update to the study page's software or content management system.
    Difference
    0.1%
    Check dated 2026-06-08T15:24:22.000Z thumbnail image
  3. Check
    21 days ago
    No Change Detected
  4. Check
    28 days ago
    No Change Detected
  5. Check
    35 days ago
    Change Detected
    Summary
    The page's revision label was updated from v3.5.3 to v3.5.4. This indicates a minor patch to the page.
    Difference
    0.1%
    Check dated 2026-05-18T03:53:24.000Z thumbnail image
  6. Check
    56 days ago
    Change Detected
    Summary
    This updates the ClinicalTrials.gov page’s visible revision/version label from v3.5.2 to v3.5.3 without changing any underlying study details.
    Difference
    0.1%
    Check dated 2026-04-26T15:25:13.000Z thumbnail image
  7. Check
    63 days ago
    Change Detected
    Summary
    Added Revision: v3.5.2 and removed Revision: v3.5.0.
    Difference
    0.1%
    Check dated 2026-04-19T13:40:14.000Z thumbnail image
  8. Check
    92 days ago
    Change Detected
    Summary
    Revision updated from v3.4.3 to v3.5.0. No visible changes to study content or page functionality.
    Difference
    0.1%
    Check dated 2026-03-21T17:37:17.000Z thumbnail image

Stay in the know with updates to BBP-398 + Osimertinib in EGFR+ NSCLC: Clinical Trial

Enter your email address, and we'll notify you when there's something new on the BBP-398 + Osimertinib in EGFR+ NSCLC: Clinical Trial page.